HUP0303355A3 - Stable pergolide mesylate and process for making same - Google Patents

Stable pergolide mesylate and process for making same

Info

Publication number
HUP0303355A3
HUP0303355A3 HU0303355A HUP0303355A HUP0303355A3 HU P0303355 A3 HUP0303355 A3 HU P0303355A3 HU 0303355 A HU0303355 A HU 0303355A HU P0303355 A HUP0303355 A HU P0303355A HU P0303355 A3 HUP0303355 A3 HU P0303355A3
Authority
HU
Hungary
Prior art keywords
making same
pergolide mesylate
stable
stable pergolide
mesylate
Prior art date
Application number
HU0303355A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HUP0303355A2 publication Critical patent/HUP0303355A2/hu
Publication of HUP0303355A3 publication Critical patent/HUP0303355A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
HU0303355A 2000-08-08 2001-08-07 Stable pergolide mesylate and process for making same HUP0303355A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22377400P 2000-08-08 2000-08-08
PCT/US2001/024713 WO2002011727A1 (en) 2000-08-08 2001-08-07 Stable pergolide mesylate and process for making same

Publications (2)

Publication Number Publication Date
HUP0303355A2 HUP0303355A2 (hu) 2004-01-28
HUP0303355A3 true HUP0303355A3 (en) 2005-06-28

Family

ID=22837926

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303355A HUP0303355A3 (en) 2000-08-08 2001-08-07 Stable pergolide mesylate and process for making same

Country Status (8)

Country Link
US (1) US6689384B2 (hu)
EP (1) EP1318813A4 (hu)
JP (1) JP2004505917A (hu)
AU (1) AU2001286418A1 (hu)
CA (1) CA2418915A1 (hu)
HU (1) HUP0303355A3 (hu)
IL (1) IL154290A0 (hu)
WO (1) WO2002011727A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154290A0 (en) 2000-08-08 2003-09-17 Teva Pharma Stable pergolide mesylate and process for making same
WO2003080030A1 (en) * 2002-03-26 2003-10-02 Bernard Charles Sherman Stable tablets comprising pergolide mesylate
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
MX2007001850A (es) * 2004-08-13 2007-03-28 Boehringer Ingelheim Int Formulacion de pildora de liberacion prolongada que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para fabricarlo y uso del mismo.
EP1781260B2 (en) * 2004-08-13 2014-04-02 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
CN101031322A (zh) * 2004-10-01 2007-09-05 日本脏器制药株式会社 固体药物制剂
TWM281293U (en) * 2005-05-06 2005-11-21 Harvatek Corp Optoelectronic chip array package structure
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
IL154290A0 (en) 2000-08-08 2003-09-17 Teva Pharma Stable pergolide mesylate and process for making same

Also Published As

Publication number Publication date
EP1318813A4 (en) 2005-09-07
JP2004505917A (ja) 2004-02-26
EP1318813A1 (en) 2003-06-18
US20020054904A1 (en) 2002-05-09
AU2001286418A1 (en) 2002-02-18
HUP0303355A2 (hu) 2004-01-28
WO2002011727A1 (en) 2002-02-14
CA2418915A1 (en) 2002-02-14
US6689384B2 (en) 2004-02-10
IL154290A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
TW474169U (en) Absorbent article and method for making the same
EP1354581A4 (en) POROUS SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
IL154521A0 (en) Contraception process and administration form for the same
HUP0301252A3 (en) Endoparasiticidal agents based on starch and process for their preparation
HUP0303568A3 (en) Benzothiophene derivatives, process for their preparation and use thereof
AP2001002305A0 (en) Improved prosthesis and method thereof
PL345607A1 (en) Method of and apparatus for making stick-like articles
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
IL154422A0 (en) Paroxetine compositions and processes for making the same
HUP0303355A3 (en) Stable pergolide mesylate and process for making same
SG91327A1 (en) Water-decomposable absorbent article and method for producing it
SG96218A1 (en) Sic-formed materials and method for manufacturing same
EP1414641A4 (en) IMPROVEMENTS IN A PIQURE-LINKED ETOFF AND METHOD FOR MANUFACTURING THE SAME
AU2000239097A8 (en) Manufacturing apparatus and method
HK1062180A1 (en) Process for making polyurethaneurea powder
GB0014580D0 (en) Appatarus and process
GB0014584D0 (en) Apparatus and process
HUP0301384A2 (en) Urotensin-ii agonists and antagonists
GB0024046D0 (en) Method of making porous articles
EP1310503A4 (en) PROCESS FOR THE PRODUCTION OF HYDRAZINOMONOSACCHARIDE DERIVATIVES AND THEIR USE
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
GB0008443D0 (en) Flavourig agent and methods for preparing and using same
IL156160A0 (en) Klainetins and their derivatives, method for their preparation and use thereof
HUP0204393A3 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees